Meenu Chhabra's Net Worth
-$84 Thousand
Who is Meenu Chhabra?
Meenu Chhabra does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PROTEOSTASIS THERAPEUTICS, INC., Apexigen, Inc., Vallon Pharmaceuticals, Inc., and MACROGENICS INC.
SEC CIK
Meenu Chhabra's CIK is 0001534200
Past Insider Trading and Trends
2023 was Meenu Chhabra's most active year for acquiring shares with 4 total transactions. Meenu Chhabra's most active month to acquire stocks was the month of April. 2019 was Meenu Chhabra's most active year for disposing of shares, totalling 2 transactions. Meenu Chhabra's most active month to dispose stocks was the month of January. 2017 saw Meenu Chhabra paying a total of $200,000.00 for 265,000 shares, this is the most they've acquired in one year. In 2019 Meenu Chhabra cashed out on 63,353 shares for a total of $49,305.47, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PROTEOSTASIS THERAPEUTICS, INC. (KA) Snapshot price: $0.65
President and CEOMeenu Chhabra owns 80,615 units of Common Stock which is worth $52,399.75. In the year 2016 Meenu Chhabra filed a total of 10 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +60.53% | 30.4K |
$2.99 | -$49,305.47 | 80.61K |
Scheduled
|
Feb 1 - Feb 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +391.47% | 40K |
$5.00 | $200,000.00 | 50.22K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
∞
| 10.22K |
—
|
—
| 10.22K |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Apexigen, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vallon Pharmaceuticals, Inc. (GRI) Snapshot price: $0.525
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MACROGENICS INC (MGNX) Snapshot price: $3.1701
InvestorMeenu Chhabra owns 4,500 units of Common Stock which is worth $14,265.45. In the year 2023 Meenu Chhabra acquired a total of 4,500 shares in MACROGENICS INC.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
∞
| 4.5K |
—
|
—
| 4.5K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||